GlassScriptPhysician profile
Joel K Troop
NPI 1043274798
$6,223.32
in general payments reported to CMS, 2019-2025
27 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $219 · 2021: $2,743 · 2022: $2,606 · 2023: $48.95 · 2024: $151 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $4,839.39 | 2020-2022 | |
| Pacira Therapeutics, INC. | $319.97 | 2019-2021 | |
| Depuy Synthes Sales INC. | $205.91 | 2020-2025 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $124.40 | 2022-2025 | Zilretta, Iovera, Exparel |
| Stryker Corporation | $87.42 | 2022 | |
| Ferring Pharmaceuticals INC. | $60.02 | 2019-2024 | Euflexxa |
| Orthalign INC | $55.22 | 2021 | |
| Nevro Corp. | $50.42 | 2020-2022 | |
| Spinal Simplicity, LLC | $45.04 | 2021 | |
| Bioventus LLC | $44.22 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Teva Pharmaceuticals USA, INC. | $41.89 | 2021 | |
| Spr Therapeutics, INC | $37.92 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $34.64 | 2020-2021 | |
| Curonix LLC | $29.21 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $27.79 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Naviswiss, INC. | $27.54 | 2025 | Naviswiss Hip/Knee Navigation |
| Omnilife Science, INC | $22.41 | 2019 | |
| Organogenesis INC. | $21.49 | 2024 | |
| Fidia Pharma USA INC. | $20.59 | 2019 | |
| Globus Medical, INC. | $19.69 | 2025 | Senza |
| Virtus Pharmaceuticals LLC | $19.43 | 2021 | |
| Innovation Technologies INC | $19.21 | 2024 | Irrisept |
| Avanos Medical | $16.28 | 2019 | |
| Medtronic, INC. | $14.56 | 2021 | |
| Azurity Pharmaceuticals, INC. | $14.05 | 2023 | Horizant |
| Sanofi-Aventis U.S. LLC | $12.46 | 2020 | |
| Almatica Pharma LLC | $12.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Troop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.